Table of Content

1 INTRODUCTION 25
1.1 OBJECTIVES OF THE STUDY 25
1.2 MARKET DEFINITION 25
1.2.1 INCLUSIONS & EXCLUSIONS 26
1.3 MARKET SCOPE 26
1.3.1 MARKETS COVERED 26
1.3.2 YEARS CONSIDERED FOR THE STUDY 27
1.4 CURRENCY USED FOR THE STUDY 27
1.5 MAJOR MARKET STAKEHOLDERS 27
1.6 SUMMARY OF CHANGES 28
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
FIGURE 1 RESEARCH DESIGN 29
2.1.1 SECONDARY DATA 30
2.1.1.1 Secondary sources 31
2.1.2 PRIMARY DATA 31
FIGURE 2 BREAKDOWN OF PRIMARIES: CONTINUOUS RENAL REPLACEMENT
THERAPY MARKET 32
2.2 MARKET ESTIMATION METHODOLOGY 32
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 33
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 33
2.2.2 USAGE-BASED MARKET ESTIMATION 34
FIGURE 4 ESTIMATION OF CRRT PROCEDURES 34
FIGURE 5 MARKET SIZE ESTIMATION: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BASED ON PRODUCT UTILIZATION METHODOLOGY 35
FIGURE 6 MARKET SIZE ESTIMATION: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BASED ON REVENUE MAPPING METHODOLOGY 35
2.2.3 PRIMARY RESEARCH VALIDATION 36
2.3 DATA TRIANGULATION 36
FIGURE 7 DATA TRIANGULATION METHODOLOGY 37
2.4 RESEARCH ASSUMPTIONS 37
2.5 RESEARCH LIMITATIONS 38
3 EXECUTIVE SUMMARY 39
FIGURE 8 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 39
FIGURE 9 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY,
2021 VS. 2026 (USD MILLION) 40
FIGURE 10 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2021 VS. 2026 (USD MILLION) 40
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE CONTINUOUS RENAL
REPLACEMENT THERAPY MARKET 41
4 PREMIUM INSIGHTS 43
4.1 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET OVERVIEW 43
FIGURE 12 RISING PREVALENCE OF AKI AND GROWING AWARENESS ABOUT CRRT TO DRIVE MARKET GROWTH 43
4.2 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SHARE, BY AGE GROUP, 2021 44
FIGURE 13 ADULTS SEGMENT TO DOMINATE THE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET IN 2021 44
4.3 ASIA PACIFIC: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT AND COUNTRY 45
FIGURE 14 DIALYSATES AND REPLACEMENT FLUIDS ACCOUNT FOR THE LARGEST SHARE OF THE CRRT PRODUCTS MARKET IN THE APAC 45
FIGURE 15 APAC MARKET TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD (2021–2026) 46
5 MARKET OVERVIEW 47
5.1 INTRODUCTION 47
5.2 MARKET DYNAMICS 47
FIGURE 16 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 47
5.2.1 DRIVERS 48
5.2.1.1 Increasing incidence of acute kidney injury (AKI) 48
FIGURE 17 GLOBAL INCIDENCE OF AKI, 2010 VS. 2015 VS. 2020 48
TABLE 1 NUMBER OF PEOPLE AGED 65 YEARS OR OVER, BY REGION, 2019 VS. 2050 49
5.2.1.2 Growing number of ICU patients with AKI and increasing incidence of sepsis 49
FIGURE 18 IMPACT OF ICU-ACQUIRED AKI IN THE US 50
5.2.1.3 Increasing clinical advantage of CRRT over intermittent blood purification 50
5.2.1.4 Technological advancements and new product launches 51
5.2.1.5 Growing prevalence of diabetes and hypertension 51
FIGURE 19 TOP 5 COUNTRIES WITH CHILDREN AND ADOLESCENTS WITH TYPE I DIABETES, 2019 52
5.2.2 RESTRAINTS 52
5.2.2.1 Stringent regulatory guidelines in North America 52
5.2.2.2 High procedural cost of CRRT 52
5.2.3 OPPORTUNITIES 53
5.2.3.1 Emerging markets in APAC and RoW 53
5.2.3.2 Increasing applications of CRRT 53
5.2.3.2.1 Evolution of CRRT from a simple renal replacement treatment to multi-organ support therapy 53
5.2.3.2.2 Progression of CRRT from adaptive renal devices to multipurpose treatment machines 54
?
5.2.3.3 Ongoing research to establish the safety and efficacy profile of CRRT 54
5.2.3.4 Development of CRRT systems for pediatric patients 54
5.2.3.4.1 The CARPEDIEM Project 55
5.2.3.5 Untapped growth opportunities in North America 55
5.2.4 CHALLENGES 55
5.2.4.1 High complexity of CRRT 55
5.2.4.2 Lack of standard treatment guidelines in developing nations 56
5.2.4.3 Shortage of trained ICU professionals in developing nations 56
5.2.4.4 Poor reimbursement scenario in developing countries 56
5.2.4.5 Lack of awareness about the benefits of CRRT 57
5.3 GLOBAL REGULATORY LANDSCAPE 57
5.3.1 NORTH AMERICA 57
5.3.2 EUROPE 57
5.3.3 ASIA PACIFIC 58
5.3.3.1 India 58
5.3.3.2 China 58
5.3.3.3 Japan 58
5.3.3.4 South Korea 58
5.3.4 REST OF THE WORLD (ROW) 58
5.3.4.1 Brazil 58
5.3.4.2 Argentina 59
5.4 GLOBAL REIMBURSEMENT SCENARIO 59
5.4.1 NORTH AMERICA 59
5.4.2 EUROPE 59
5.4.3 ASIA PACIFIC 60
5.4.4 JAPAN 60
5.4.5 REST OF THE WORLD (ROW) 61
5.4.5.1 Brazil 61
5.4.5.2 Central America and the Caribbean 61
5.5 COVID-19 IMPACT ON THE CRRT MARKET 61
FIGURE 20 US: COVID-19 HOSPITALIZATION DATA FOR SPECIALIZED MEDICAL CONDITIONS IN ADULTS (AS OF APRIL 11, 2020) 62
5.6 VALUE CHAIN ANALYSIS 63
FIGURE 21 VALUE CHAIN OF THE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET 63
5.7 ECOSYSTEM COVERAGE 64
5.8 PRICING TREND ANALYSIS 64
TABLE 2 AVERAGE PRICE OF CRRT SYSTEMS AND CONSUMABLES, BY COUNTRY, 2020 (USD) 64
5.9 PORTER’S FIVE FORCES ANALYSIS 65
TABLE 3 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS 65
5.9.1 THREAT FROM NEW ENTRANTS 65
FIGURE 22 THREAT FROM NEW ENTRANTS 66
5.9.2 THREAT FROM SUBSTITUTES 66
FIGURE 23 THREAT FROM SUBSTITUTES 66
5.9.3 BARGAINING POWER OF SUPPLIERS 66
FIGURE 24 BARGAINING POWER OF SUPPLIERS 67
5.9.4 BARGAINING POWER OF BUYERS 67
FIGURE 25 BARGAINING POWER OF BUYERS 67
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 68
FIGURE 26 INTENSITY OF COMPETITIVE RIVALRY 68
6 GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY PRODUCT 69
6.1 INTRODUCTION 70
TABLE 4 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 70
6.2 DIALYSATES & REPLACEMENT FLUIDS 70
6.2.1 RISING DEMAND FOR DIALYSATES HAS SUPPORTED MARKET GROWTH 70
TABLE 5 DIALYSATES & REPLACEMENT FLUIDS MARKET, BY MODALITY,
2019–2026 (USD MILLION) 71
TABLE 6 DIALYSATES & REPLACEMENT FLUIDS MARKET, BY AGE GROUP,
2019–2026 (USD MILLION) 71
TABLE 7 DIALYSATES & REPLACEMENT FLUIDS MARKET, BY REGION,
2019–2026 (USD MILLION) 72
6.3 DISPOSABLES 72
TABLE 8 DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 72
TABLE 9 DISPOSABLES MARKET, BY MODALITY, 2019–2026 (USD MILLION) 73
TABLE 10 DISPOSABLES MARKET, BY AGE GROUP, 2019–2026 (USD MILLION) 73
TABLE 11 DISPOSABLES MARKET, BY REGION, 2019–2026 (USD MILLION) 73
6.3.1 HEMOFILTERS 74
6.3.1.1 Hemofilters are widely adopted during CRRT procedures for the treatment of AKI 74
TABLE 12 HEMOFILTERS MARKET, BY REGION, 2019–2026 (USD MILLION) 74
TABLE 13 HEMOFILTERS MARKET, BY MODALITY, 2019–2026 (USD MILLION) 74
TABLE 14 HEMOFILTERS MARKET, BY AGE GROUP, 2019–2026 (USD MILLION) 75
6.3.2 BLOODLINE SETS & TUBES 75
6.3.2.1 Established players are focusing on strengthening their bloodline sets and tubes product lines 75
TABLE 15 BLOODLINE SETS & TUBES MARKET, BY REGION, 2019–2026 (USD MILLION) 76
TABLE 16 BLOODLINE SETS & TUBES MARKET, BY MODALITY,
2019–2026 (USD MILLION) 76
TABLE 17 BLOODLINE SETS & TUBES MARKET, BY AGE GROUP,
2019–2026 (USD MILLION) 76
6.3.3 OTHER DISPOSABLES 77
TABLE 18 OTHER DISPOSABLES MARKET, BY REGION, 2019–2026 (USD MILLION) 77
TABLE 19 OTHER DISPOSABLES MARKET, BY MODALITY, 2019–2026 (USD MILLION) 77
TABLE 20 OTHER DISPOSABLES MARKET, BY AGE GROUP, 2019–2026 (USD MILLION) 78
6.4 CRRT SYSTEMS 78
6.4.1 INTRODUCTION OF ADVANCED PRODUCTS TO DRIVE THE DEMAND
FOR CRRT SYSTEMS 78
TABLE 21 CRRT SYSTEMS MARKET, BY MODALITY, 2019–2026 (USD MILLION) 79
TABLE 22 CRRT SYSTEMS MARKET, BY AGE GROUP, 2019–2026 (USD MILLION) 79
TABLE 23 CRRT SYSTEMS MARKET BY REGION, 2019–2026 (USD MILLION) 79
7 GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY MODALITY 80
7.1 INTRODUCTION 81
TABLE 24 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2019–2026 (USD MILLION) 81
7.2 CONTINUOUS VENOVENOUS HEMOFILTRATION 82
7.2.1 WIDESPREAD ADOPTION OF CVVH IN THE TREATMENT OF ACUTE KIDNEY INJURY TO DRIVE MARKET GROWTH 82
TABLE 25 CONTINUOUS VENOVENOUS HEMOFILTRATION MARKET, BY REGION,
2019–2026 (USD MILLION) 82
7.3 CONTINUOUS VENOVENOUS HEMODIAFILTRATION 83
7.3.1 CVVHDF IS USED IN PATIENTS WITH CONGESTIVE HEART FAILURE 83
TABLE 26 CONTINUOUS VENOVENOUS HEMODIAFILTRATION MARKET, BY REGION, 2019–2026 (USD MILLION) 83
7.4 CONTINUOUS VENOVENOUS HEMODIALYSIS 83
7.4.1 THIS THERAPY IS MORE EFFECTIVE IN REMOVING SMALL TO MEDIUM-SIZED MOLECULES AS COMPARED TO OTHER CRRT MODALITIES 83
TABLE 27 CONTINUOUS VENOVENOUS HEMODIALYSIS MARKET, BY REGION,
2019–2026 (USD MILLION) 84
7.5 SLOW CONTINUOUS ULTRAFILTRATION 84
7.5.1 SCUF DOES NOT USE DIALYSATES OR REPLACEMENT FLUIDS FOR THE REMOVAL OF EXCESS FLUID FROM THE BLOODSTREAM 84
TABLE 28 SLOW CONTINUOUS ULTRAFILTRATION MARKET, BY REGION,
2019–2026 (USD MILLION) 85
8 GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP 86
8.1 INTRODUCTION 87
TABLE 29 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2019–2026 (USD MILLION) 87
8.2 ADULTS 87
8.2.1 ADULTS HOLD THE LARGEST SHARE OF THE MARKET BY AGE GROUP 87
TABLE 30 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET FOR ADULTS,
BY REGION, 2019–2026 (USD MILLION) 88
8.3 PEDIATRICS & NEONATES 88
8.3.1 HIGH PREVALENCE OF AKI IN NEONATES TO AID THE MARKET GROWTH DURING THE FORECAST PERIOD 88
TABLE 31 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET FOR PEDIATRICS & NEONATES, BY REGION, 2019–2026 (USD MILLION) 89
9 GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY REGION 90
9.1 INTRODUCTION 91
TABLE 32 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY REGION,
2019–2026 (USD MILLION) 91
9.2 EUROPE 92
FIGURE 27 EUROPE: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SNAPSHOT 92
TABLE 33 EUROPE: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 93
TABLE 34 EUROPE: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 93
TABLE 35 EUROPE: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 93
TABLE 36 EUROPE: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY MODALITY, 2019–2026 (USD MILLION) 94
TABLE 37 EUROPE: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY AGE GROUP, 2019–2026 (USD MILLION) 94
9.2.1 GERMANY 95
9.2.1.1 Germany is the largest market for continuous renal replacement therapy in Europe 95
TABLE 38 GERMANY: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 95
TABLE 39 GERMANY: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 95
9.2.2 UK 96
9.2.2.1 Rising number of sepsis cases in the UK to support market growth 96
TABLE 40 UK: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 96
TABLE 41 UK: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 97
9.2.3 FRANCE 97
9.2.3.1 France is the fastest-growing market for CRRT in Europe 97
TABLE 42 FRANCE: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 97
TABLE 43 FRANCE: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 98
9.2.4 ITALY 98
9.2.4.1 Government initiatives to promote the awareness of CRRT for renal care to drive market growth 98
TABLE 44 ITALY: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 98
TABLE 45 ITALY: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION 99
9.2.5 SPAIN 99
9.2.5.1 Favorable reimbursement scenario to favor market growth 99
TABLE 46 SPAIN: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 99
TABLE 47 SPAIN: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 100
9.2.6 REST OF EUROPE 100
TABLE 48 ROE: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 100
TABLE 49 ROE: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 101
9.3 NORTH AMERICA 101
TABLE 50 NORTH AMERICA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 101
TABLE 51 NORTH AMERICA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 102
TABLE 52 NORTH AMERICA: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 102
TABLE 53 NORTH AMERICA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY MODALITY, 2019–2026 (USD MILLION) 103
TABLE 54 NORTH AMERICA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY AGE GROUP, 2019–2026 (USD MILLION) 103
9.3.1 US 103
9.3.1.1 Large number of AKI patients in the region to drive the market growth 103
TABLE 55 US: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 104
TABLE 56 US: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 105
9.3.2 CANADA 105
9.3.2.1 High cost of CRRT as compared to IHD is negatively impacting market growth in Canada 105
TABLE 57 CANADA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 106
TABLE 58 CANADA: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 106
9.4 ASIA PACIFIC 106
FIGURE 28 APAC: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SNAPSHOT 107
TABLE 59 APAC: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 107
TABLE 60 APAC: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 108
TABLE 61 APAC: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 108
TABLE 62 APAC: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2019–2026 (USD MILLION) 109
TABLE 63 APAC: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2019–2026 (USD MILLION) 109
9.4.1 JAPAN 109
9.4.1.1 Increasing use of CRRT to boost the market in Japan 109
TABLE 64 JAPAN: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 110
TABLE 65 JAPAN: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 110
9.4.2 CHINA 111
9.4.2.1 Increasing prevalence of ESRD and AKI to boost the
demand for CRRT 111
TABLE 66 CHINA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 111
TABLE 67 CHINA: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 112
9.4.3 INDIA 112
9.4.3.1 Growing number of AKI patients and ICU admissions to support market growth 112
TABLE 68 INDIA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 113
TABLE 69 INDIA: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 113
9.4.4 AUSTRALIA 113
9.4.4.1 The Australian government is taking various initiatives to increase the awareness of CRRT 113
TABLE 70 AUSTRALIA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 114
TABLE 71 AUSTRALIA: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 114
9.4.5 SOUTH KOREA 114
9.4.5.1 The country is witnessing an increasing number of patients receiving CRRT for the treatment of AKI 114
TABLE 72 SOUTH KOREA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 115
TABLE 73 SOUTH KOREA: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 115
9.4.6 REST OF ASIA PACIFIC 115
TABLE 74 REST OF ASIA PACIFIC: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 116
TABLE 75 REST OF ASIA PACIFIC: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 116
9.5 LATIN AMERICA 117
TABLE 76 LATIN AMERICA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 117
TABLE 77 LATIN AMERICA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 117
TABLE 78 LATIN AMERICA: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 118
TABLE 79 LATIN AMERICA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY MODALITY, 2019–2026 (USD MILLION) 118
TABLE 80 LATIN AMERICA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY AGE GROUP, 2019–2026 (USD MILLION) 119
9.5.1 BRAZIL 119
9.5.1.1 Brazil holds the largest share in the Latin American CRRT market 119
TABLE 81 BRAZIL: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 119
TABLE 82 BRAZIL: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 120
9.5.2 MEXICO 120
9.5.2.1 Large patient population and growing middle-class population to support market growth in Mexico 120
TABLE 83 MEXICO: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 120
TABLE 84 MEXICO: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 121
9.5.3 REST OF LATIN AMERICA 121
TABLE 85 REST OF LATIN AMERICA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 121
TABLE 86 REST OF LATIN AMERICA: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 122
9.6 MIDDLE EAST & AFRICA 122
9.6.1 LACK OF AWARENESS REGARDING CRRT TO RESTRAIN THE MARKET GROWTH IN THE REGION 122
TABLE 87 MEA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 122
TABLE 88 MEA: CONTINUOUS RENAL REPLACEMENT THERAPY DISPOSABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 123
TABLE 89 MEA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY MODALITY, 2019–2026 (USD MILLION) 123
TABLE 90 MEA: CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, BY AGE GROUP, 2019–2026 (USD MILLION) 124
10 COMPETITIVE LANDSCAPE 125
10.1 OVERVIEW 125
10.2 KEY PLAYER STRATEGIES 125
10.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 126
FIGURE 29 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE CRRT MARKET 126
10.4 GLOBAL MARKET SHARE ANALYSIS (2020) 126
TABLE 91 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET: DEGREE OF COMPETITION 126
10.5 COMPETITIVE LEADERSHIP MAPPING 128
10.5.1 STARS 128
10.5.2 EMERGING LEADERS 128
10.5.3 PERVASIVE PLAYERS 128
10.5.4 PARTICIPANTS 128
FIGURE 30 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020 129
?
10.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2020) 129
10.6.1 PROGRESSIVE COMPANIES 129
10.6.2 STARTING BLOCKS 130
10.6.3 RESPONSIVE COMPANIES 130
10.6.4 DYNAMIC COMPANIES 130
FIGURE 31 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2020 131
10.7 FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET 131
10.7.1 PRODUCT AND GEOGRAPHICAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET 131
TABLE 92 INDUSTRY FOOTPRINT OF COMPANIES 132
TABLE 93 REGIONAL FOOTPRINT OF COMPANIES 133
10.7.1.1 Continuous renal replacement therapy market: Product launches and regulatory approvals (January 2018 to May 2021) 134
TABLE 94 KEY PRODUCT LAUNCHES AND REGULATORY APPROVALS 134
10.7.1.2 Continuous renal replacement therapy market: Deals
(January 2018 to May 2021) 135
TABLE 95 KEY DEALS 135
10.7.1.3 Continuous renal replacement therapy market: Other developments (January 2018 to May 2021) 136
TABLE 96 KEY OTHER DEVELOPMENTS 136
11 COMPANY PROFILES 137
11.1 MAJOR PLAYERS 137
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 BAXTER INTERNATIONAL INC. 137
TABLE 97 BAXTER INTERNATIONAL INC.: BUSINESS OVERVIEW 137
FIGURE 32 COMPANY SNAPSHOT: BAXTER INTERNATIONAL INC. 138
TABLE 98 BAXTER INTERNATIONAL INC.: PRODUCT OFFERINGS 138
11.1.2 FRESENIUS MEDICAL CARE AG & CO. KGAA 141
TABLE 99 FRESENIUS MEDICAL CARE AG & CO. KGAA: BUSINESS OVERVIEW 141
FIGURE 33 COMPANY SNAPSHOT: FRESENIUS MEDICAL CARE AG & CO. KGAA 142
TABLE 100 FRESENIUS MEDICAL CARE AG & CO. KGAA: PRODUCT OFFERINGS 143
11.1.3 NIKKISO CO., LTD. 145
TABLE 101 NIKKISO CO., LTD.: BUSINESS OVERVIEW 145
FIGURE 34 COMPANY SNAPSHOT: NIKKISO CO., LTD. 146
TABLE 102 NIKKISO CO., LTD.: PRODUCT OFFERINGS 147
11.1.4 B. BRAUN MELSUNGEN AG 148
TABLE 103 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW 148
FIGURE 35 COMPANY SNAPSHOT: B. BRAUN MELSUNGEN AG 149
TABLE 104 B. BRAUN MELSUNGEN AG: PRODUCT OFFERINGS 149
11.1.5 MEDTRONIC PLC 151
TABLE 105 MEDTRONIC PLC: BUSINESS OVERVIEW 151
FIGURE 36 COMPANY SNAPSHOT: MEDTRONIC PLC 152
TABLE 106 MEDTRONIC PLC: PRODUCT OFFERINGS 152
11.1.6 ASAHI KASEI CORPORATION 154
TABLE 107 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW 154
FIGURE 37 COMPANY SNAPSHOT: ASAHI KASEI CORPORATION 155
TABLE 108 ASAHI KASEI CORPORATION: PRODUCT OFFERINGS 155
11.1.7 TORAY MEDICAL CO., LTD. 156
TABLE 109 TORAY MEDICAL CO., LTD.: BUSINESS OVERVIEW 156
FIGURE 38 COMPANY SNAPSHOT: TORAY MEDICAL CO., LTD. 157
TABLE 110 TORAY MEDICAL CO., LTD.: PRODUCT OFFERINGS 157
11.1.8 NIPRO CORPORATION 158
TABLE 111 NIPRO CORPORATION: BUSINESS OVERVIEW 158
FIGURE 39 COMPANY SNAPSHOT: NIPRO CORPORATION 158
TABLE 112 NIPRO CORPORATION: PRODUCT OFFERINGS 159
11.1.9 INFOMED SA 160
TABLE 113 INFOMED SA: BUSINESS OVERVIEW 160
TABLE 114 INFOMED SA: PRODUCT OFFERINGS 160
11.1.10 MEDICA SPA 162
TABLE 115 MEDICA SPA: BUSINESS OVERVIEW 162
11.1.10.2 Products offered 162
TABLE 116 MEDICA SPA: PRODUCT OFFERINGS 162
11.1.11 MEDITES PHARMA SPOL. S.R.O 164
TABLE 117 MEDITES PHARMA SPOL. S.R.O: BUSINESS OVERVIEW 164
TABLE 118 MEDITES PHARMA SPOL. S.R.O: PRODUCT OFFERINGS 164
11.1.12 MEDICAL COMPONENTS, INC. 165
TABLE 119 MEDICAL COMPONENTS, INC.: BUSINESS OVERVIEW 165
TABLE 120 MEDICAL COMPONENTS, INC.: PRODUCT OFFERINGS 165
11.1.13 SWS HEMODIALYSIS CARE CO. LTD. 167
TABLE 121 SWS HEMODIALYSIS CARE CO. LTD.: BUSINESS OVERVIEW 167
TABLE 122 SWS HEMODIALYSIS CARE CO. LTD.: PRODUCT OFFERINGS 167
11.1.14 NINGBO TIANYI MEDICAL DEVICES CO., LTD. 169
TABLE 123 NINGBO TIANYI MEDICAL DEVICES CO., LTD.: BUSINESS OVERVIEW 169
TABLE 124 NINGBO TIANYI MEDICAL DEVICES CO., LTD.: PRODUCT OFFERINGS 169
11.1.15 ANJUE MEDICAL EQUIPMENT CO., LTD. 170
TABLE 125 ANJUE MEDICAL EQUIPMENT CO., LTD.: BUSINESS OVERVIEW 170
TABLE 126 ANJUE MEDICAL EQUIPMENT CO., LTD.: PRODUCT OFFERINGS 170
11.2 EMERGING PLAYERS 171
11.2.1 KIMAL 171
11.2.2 JIANGXI SANXIN MEDTEC CO., LTD. 171
11.2.3 ALLMED MEDICAL PRODUCTS CO., LTD. 172
11.2.4 DIALCO MEDICAL INC. 172
11.2.5 BROWNDOVE HEALTHCARE PVT. LTD. 173
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 174
12.1 DISCUSSION GUIDE 174
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 178
12.3 AVAILABLE CUSTOMIZATIONS 180
12.4 RELATED REPORTS 180
12.5 AUTHOR DETAILS 181